Webinar: How People Affected by HCV & TB Feel About Potential Long-Acting Therapies – Materials Now Available Online

4 June 2025

On 30 May 2025, Treatment Action Group and Afrocab hosted a webinar to share findings from surveys conducted under the Unitaid-funded LONGEVITY Project to understand HCV and TB end user and healthcare providers/policy maker preferences and attitudes towards three long-acting modalities namely: injections, implants and microarray patches (MAPs), and explore challenges and opportunities for these long-acting treatment modalities.

Recording of the webinar and slides presented are now available online and can be accessed here.